Immediate Effect of Dry Needling on Trigger Points

Sponsor
Université de Sherbrooke (Other)
Overall Status
Completed
CT.gov ID
NCT04476381
Collaborator
(none)
48
1
1
19.6
2.5

Study Details

Study Description

Brief Summary

The immediate effects (0-30 minutes) of a dry needling intervention on a trigger point on their viscoelastic properties (tone, elasticity and stiffness)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dry needling
N/A

Detailed Description

Objectives: To investigate the immediate effects of a dry needling puncture on the viscoelastic properties (tone, stiffness and elasticity) of a trigger point (TP) located in the infraspinatus muscle in participants with non-traumatic chronic shoulder pain.

Methods: Forty-eight individuals who presented non-traumatic chronic shoulder pain were recruited. The presence of a TP in the infraspinatus muscle of the painful side was confirmed by an experienced physiotherapist with a palpatory exam according to Travell and Simons criteria. The TP was marked and the viscoelastic properties including tone, stiffness and elasticity were measured with the MyotonPro device by an evaluator. After the first set of measurements (T1), an experienced physiotherapist applied a dry needling puncture to the TP with a pistoning technique to obtain a local twitch response (LTR) with an Optimed 40 x 0.30 mm single use acupuncture needle. The same set of measurements was repeated immediately after the dry needling (T2) and 30 minutes later (T3). Repeated measures ANOVA and post-hoc tests were used to assess changes in viscoelastic properties over time with a significant level set at 0.05.

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
One group, one measurement of the viscoelastic properties with the MyotonPro of a single trigger point before the dry needle insertion, one measurement with the MyotonPro right after and 30 minutes laterOne group, one measurement of the viscoelastic properties with the MyotonPro of a single trigger point before the dry needle insertion, one measurement with the MyotonPro right after and 30 minutes later
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Immediate Effect of Dry Needling on the Viscoelastic Properties of a Trigger Point on the Infraspinatus Muscle Measured With the MyotonPro
Actual Study Start Date :
Feb 1, 2018
Actual Primary Completion Date :
Jun 7, 2018
Actual Study Completion Date :
Sep 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dry needling of a trigger point in the infraspinatus muscle

Insertion a a acupuncture type needle into a trigger point in the infraspinatus muscle on the painful side to decrease the stiffness and tone and increase the elasticity

Procedure: Dry needling
Insertion of a Optimed 40mm x 0.30 single use, sterile acupuncture needle into a active trigger point in the infraspinatus muscle

Outcome Measures

Primary Outcome Measures

  1. Tone in Hertz measured with a myotonometer on the trigger point [baseline]

    Measurement of the tone in Hz with the myotonometer MyotonPro on the trigger point

  2. Tone in Hertz measured with a myotonometer on the trigger point [immediately after the intervention]

    Measurement of the tone in Hz with the myotonometer MyotonPro on the trigger point

  3. Tone in Hertz measured with a myotonometer on the trigger point [30 minutes after the intervention]

    Measurement of the tone in Hz with the myotonometer MyotonPro on the trigger point

  4. Stiffness in N/m with a myotonometer on the trigger point [baseline]

    Measurement of the stiffness in N/m with the myotonometer MyotonPro on the trigger point

  5. Stiffness in N/m with a myotonometer on the trigger point [immediately after the intervention]

    Measurement of the stiffness in N/m with the myotonometer MyotonPro on the trigger point

  6. Stiffness in N/m with a myotonometer on the trigger point [30 minutes after the intervention]

    Measurement of the stiffness in N/m with the myotonometer MyotonPro on the trigger point

  7. Elasticity (no units: inversely proportional to the decrement of the oscillations) with a myotonometer on the trigger point [baseline]

    Measurement of the elasticity with the MyotonPro

  8. Elasticity (no units: inversely proportional to the decrement of the oscillations) with a myotonometer on the trigger point [immediately after the intervention]

    Measurement of the elasticity with the MyotonPro

  9. Elasticity (no units: inversely proportional to the decrement of the oscillations) with a myotonometer on the trigger point [30 minutes after the intervention]

    Measurement of the elasticity with the MyotonPro

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. present with chronic shoulder pain of non-traumatic origin (rated at least 2/10 on a numeric rating scale (NRS) for more than 3 months. The pain had to be located in the shoulder area or referred in the area of the infraspinatus as described by Travell and Simons (1999);

  2. have a hyperirritable spot within a palpable tight band that reproduced the participant's pain when compressed by palpation; and

  3. have a body mass index (BMI) lower than 28

Exclusion Criteria:
  1. diagnosis of capsulitis, cancer, or metastasis;

  2. previous shoulder or thorax surgery or a mastectomy;

  3. shoulder girdle bone fracture;

  4. C4-C5 or C6 radiculopathy;

  5. known osteoporotic profile (positive bone densitometry);

  6. apparent atrophy of the infraspinatus fossa (visual interpretation) and

  7. contraindications to receive a DN intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 CRCHUS-Physius Lab Sherbrooke Quebec Canada J1H5N4

Sponsors and Collaborators

  • Université de Sherbrooke

Investigators

  • Study Director: Nathaly Gaudreault, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mélanie Roch, Principal Investigator, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT04476381
Other Study ID Numbers:
  • MON07
First Posted:
Jul 20, 2020
Last Update Posted:
Jul 20, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mélanie Roch, Principal Investigator, Université de Sherbrooke
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2020